Clough Capital Partners’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
NIM
FHA
RCM
KIM
Clough Capital Partners's HQL Position: Q3 2025 in Review
Clough Capital Partners sold out of abrdn Life Sciences Investors (HQL) in Q3 2025, closing a stake of 24,850 shares — an estimated $318K sold.
Clough Capital Partners first reported a position in HQL in Q3 2015 and held it in 13 quarters. The position peaked at $5.05M in Q4 2023. 83 funds tracked by Wall St. Rank hold HQL as of Q3 2025.
- Clough Capital Partners reported no remaining abrdn Life Sciences Investors position as of Q3 2025 after selling out during the quarter.
- Clough Capital Partners sold 24,850 abrdn Life Sciences Investors shares in Q3 2025, an estimated $318K.
- Clough Capital Partners first reported a position in abrdn Life Sciences Investors in Q3 2015 and held it in 13 quarters.
- Clough Capital Partners's abrdn Life Sciences Investors position peaked at $5.05M in Q4 2023.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2025.
Based on Clough Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.